APLS—(-13%)—loses appeal of CHMP rejection: https://www.globenewswire.com/news-release/2024/09/20/2949536/0/en/Apellis-Receives-Negative-CHMP-Opinion-for-Pegcetacoplan-for-Geographic-Atrophy-GA-in-the-EU-Following-Re-Examination.html See #msg-174674733 for related info.